Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984269 · ClinicalTrials.gov registry record · NA
Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection
A NA study of Lymphedema, sponsored by OrthoCarolina Research Institute.
- Active
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 2
- Study locations
NCT00984269: Active NA study of Lymphedema, sponsored by OrthoCarolina Research Institute.
NCT00984269 is a NA study of Lymphedema that is active but no longer recruiting, run by OrthoCarolina Research Institute. The registered enrollment target is 67 participants, below the 9,298-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00984269, a NA study of Lymphedema, is active but no longer recruiting, sponsored by OrthoCarolina Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, randomized, equivalence trial designed to evaluate postoperative complications following hand surgery with a brachial tourniquet and without a tourniquet in patients that have previously had a mastectomy with axillary node dissection with or without radiation treatment or history of lymphedema.
Conditions Studied
Interventions
- PROCEDURE Tourniquet Use
Study Locations (2)
Michigan
- University of Michigan Medical School - Ann Arbor
North Carolina
- OrthoCarolina - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2009-08-19 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT00984269 still lists
NCT00984269 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 9,298-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Tourniquet Use is the first listed.
NCT00984269 reports a single indexed study location in Michigan, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00984269 about?
NCT00984269 is a clinical study titled "Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection". This is a prospective, randomized, equivalence trial designed to evaluate postoperative complications following hand surgery with a brachial tourniquet and without a tourniquet in patients that have previously had a mastectomy with axillary node dissection with or without radiation treatment or hist...
What is the current status of trial NCT00984269?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2009-08-19. Estimated completion is 2025-12.
What conditions does trial NCT00984269 study?
This clinical trial studies the following conditions: Lymphedema.
What interventions are being tested in trial NCT00984269?
The interventions under investigation include: Tourniquet Use (PROCEDURE).
Who is sponsoring clinical trial NCT00984269?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00984269 being conducted?
This trial has 2 study locations across Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00984269's enrollment target sits among peer trials
67 25th of 34 higher than 10 of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI